Skip to main content

Table 2 The aberrant expression of p16 INK4a or Bmi1 in molecular subtypes of breast cancer

From: Estrogen receptor α-coupled Bmi1 regulation pathway in breast cancer and its clinical implications

Subtypes

p16INK4a

Pvalue

Bmi1

Pvalue

 

-

+

 

-

+

 

LA

28

0

<0.0001

0

28

<0.0001

LB

22

4

1

25

LHP

8

0

0

8

HP

5

11

7

9

TNBC

2

12

11

3

Total

65

27

19

73

  1. Abbreviations: LA Luminal-A, LB Luminal-B, LHP Luminal-HER2-Positive, HP HER2-Positive (HER2-enriched), TNBC Triple Negative Breast Cancer.
  2. Bold face representing significant data (P<0.05).